Pee test could replace needles for bladder cancer detection
NCT ID NCT07614594
First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study is testing whether a urine test can accurately detect urothelial carcinoma, a type of cancer that includes bladder cancer. Researchers are comparing the test results to standard tissue biopsies in 800 adults with blood in their urine and suspicious imaging findings. If the urine test proves reliable, it could offer a noninvasive, cheaper way to screen for these cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- urine DNA methylation test
- What this could lead to
- If successful, this could provide a simple, noninvasive way to detect bladder and related cancers early, reducing the need for invasive biopsies.
- What could go wrong
- This is an early observational study at a single center, so results may not apply to all patients. The test may not be accurate enough to replace standard diagnostic methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER (BC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, Henan, 450003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood draw could spot bladder Cancer's return
- Can a tiny ultrasound probe see how deep a urinary tract tumor goes?
- Can a targeted drug combo boost tumor clearance in rare kidney tract cancer?
- Can a new nucleotide analogue boost cancer treatment?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can a Two-Drug attack shrink Hard-to-Treat bladder tumors?